1. Allergan, Inc. (188 from 2,284 patents)

2. Allergan Sales, Inc. (15 from 228 patents)

3. Akrivista LLC (3 from 3 patents)

4. Other (1 from 831,952 patents)

5. University of California (1 from 15,294 patents)

6. The United States Government As Represented by the Department of Veterans Affairs (1 from 879 patents)

7. Allergen Sales, Inc. (1 from 4 patents)

8. Allegran, Inc. (1 from 1 patent)

9. Invent Dcu Limited (1 from 1 patent)

10. Winston Pharmaceuticals, Inc. (1 from 1 patent)

11. Partnership of Michael E. Garst, George Sachs, and Jai Moo Shin (1 from 1 patent)

1. 12220439 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye

2. 11903986 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye

3. 11622982 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye

4. 11286234 - Phenyl urea derivatives as N-formyl peptide receptor modulators

5. 11117860 - Phenyl urea derivatives as n-formyl peptide receptor modulators

6. 11046644 - Sulfur derivatives as chemokine receptor modulators

7. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

8. 10800744 - Imidazole derivatives as formyl peptide receptor modulators

9. 10301269 - Imidazole derivatives as formyl peptide receptor modulators

10. 10287243 - Sulfur derivatives as chemokine receptor modulators

11. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

12. 10077289 - Cyclosporins modified on the MeBmt sidechain by heterocyclic rings

13. 10065992 - Cyclosporin analogs

14. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

15. 9926264 - Phenylcarbamate derivatives as formyl peptide receptor modulators